Mrna Therapy For Argininosuccinate Synthetase Deficiency

Patent No. EP3060303 (titled "Mrna Therapy For Argininosuccinate Synthetase Deficiency") was filed by Shire Human Genetic Therapies on Oct 22, 2014. The application was issued on Nov 14, 2018.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
WITHERS & ROGERS	Aug 14, 2019	GRAF VON STOSCH

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Sep 7, 2021
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Sep 7, 2021
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Sep 2, 2021
Termination of the opposition proceedings with revocation of patent
Jun 1, 2021
Decision revoking the European patent
Jun 1, 2021
Decision revoking the European patent
May 24, 2021
(Electronic) Receipt
May 24, 2021
Letter accompanying subsequently filed items
May 24, 2021
Request for revocation of patent
Apr 30, 2021
Notification concerning the date of oral proceedings
Apr 30, 2021
Notification concerning the date of oral proceedings
Apr 23, 2021
Withdrawal of a request for oral proceedings
Nov 12, 2020
Advice of delivery
Nov 5, 2020
Advice of delivery
Nov 4, 2020
Acknowledgement of a document
Nov 4, 2020
Acknowledgement of a document
Nov 4, 2020
Annex to the communication - opposition
Nov 4, 2020
Information concerning oral proceedings
Nov 4, 2020
Summons to attend oral proceedings
Nov 4, 2020
Summons to attend oral proceedings
Oct 22, 2020
Notification concerning the date of oral proceedings
Oct 12, 2020
Advice of delivery
Oct 6, 2020
Notification concerning the date of oral proceedings
Oct 6, 2020
Notification concerning the date of oral proceedings
Oct 5, 2020
Brief communication - Opposition proceedings
Oct 1, 2020
(Electronic) Receipt
Oct 1, 2020
Any annexes (other than citation) to an opposition letter
Oct 1, 2020
Auxiliary request during Opposition procedure
Oct 1, 2020
Auxiliary request during Opposition procedure
Oct 1, 2020
Auxiliary request during Opposition procedure
Oct 1, 2020
Auxiliary request during Opposition procedure - 01
Oct 1, 2020
Auxiliary request during Opposition procedure - 02
Oct 1, 2020
Auxiliary request during Opposition procedure - 03
Oct 1, 2020
Letter accompanying subsequently filed items
Oct 1, 2020
Main request during Opposition procedure
Oct 1, 2020
Main request during Opposition procedure
Oct 1, 2020
Written submission in preparation to/during oral proceedings
Sep 30, 2020
(Electronic) Receipt
Sep 30, 2020
Letter accompanying subsequently filed items
Sep 30, 2020
Written submission in preparation to/during oral proceedings
Sep 22, 2020
Notification concerning the date of oral proceedings
Sep 22, 2020
Notification concerning the date of oral proceedings
Aug 11, 2020
Brief communication - Opposition proceedings
Aug 11, 2020
Communication concerning the filing of a power of attorney
Aug 11, 2020
Communication of amended entries
Jul 29, 2020
Request for change of opponent's representative
Jul 9, 2020
Brief communication - Opposition proceedings
Jun 29, 2020
Authorisation
Jun 29, 2020
Request for change of opponent's representative
Jun 10, 2020
(Electronic) Receipt
Jun 10, 2020
Advice of delivery
Jun 10, 2020
Communication about missing advice of delivery
Jun 10, 2020
Invitation to file an authorisation
Jun 10, 2020
Letter accompanying subsequently filed items
Jun 4, 2020
Request for change of opponent's representative
May 13, 2020
Advice of delivery
Apr 30, 2020
Acknowledgement of a document
Apr 30, 2020
Acknowledgement of a document
Apr 30, 2020
Annex to the communication - opposition
Apr 30, 2020
Information concerning oral proceedings
Apr 30, 2020
Summons to attend oral proceedings
Apr 30, 2020
Summons to attend oral proceedings
Jan 10, 2020
Brief communication - Opposition proceedings
Jan 7, 2020
Consolidated list of cited opposition documents
Jan 2, 2020
(Electronic) Receipt
Jan 2, 2020
Auxiliary request during Opposition procedure
Jan 2, 2020
Auxiliary request during Opposition procedure
Jan 2, 2020
Auxiliary request during Opposition procedure
Jan 2, 2020
Auxiliary request during Opposition procedure
Jan 2, 2020
Auxiliary request during Opposition procedure - 01
Jan 2, 2020
Auxiliary request during Opposition procedure - 02
Jan 2, 2020
Auxiliary request during Opposition procedure - 03
Jan 2, 2020
Auxiliary request during Opposition procedure - 04
Jan 2, 2020
Citation in opposition procedure - 012
Jan 2, 2020
Citation in opposition procedure - 013
Jan 2, 2020
Citation in opposition procedure - 014
Jan 2, 2020
Letter accompanying subsequently filed items
Jan 2, 2020
Reply of the patent proprietor to the notice(s) of opposition
Oct 24, 2019
Brief communication - Opposition proceedings
Oct 24, 2019
Rejection of request for extension of time limit
Oct 18, 2019
(Electronic) Receipt
Oct 18, 2019
Letter accompanying subsequently filed items
Oct 18, 2019
Request for extension of time limit
Aug 27, 2019
Communication of a notice of opposition and request to file observations
Aug 27, 2019
Notice of further oppositions to opponent(s)
Aug 23, 2019
Communication of a notice of opposition - first information to patent proprietor
Aug 14, 2019
(Electronic) Receipt
Aug 14, 2019
Citation in opposition procedure - 001
Aug 14, 2019
Citation in opposition procedure - 001
Aug 14, 2019
Citation in opposition procedure - 002
Aug 14, 2019
Citation in opposition procedure - 003
Aug 14, 2019
Citation in opposition procedure - 004
Aug 14, 2019
Citation in opposition procedure - 004
Aug 14, 2019
Citation in opposition procedure - 005
Aug 14, 2019
Citation in opposition procedure - 006
Aug 14, 2019
Citation in opposition procedure - 007
Aug 14, 2019
Citation in opposition procedure - 008
Aug 14, 2019
Citation in opposition procedure - 009
Aug 14, 2019
Citation in opposition procedure - 010
Aug 14, 2019
Citation in opposition procedure - 011
Aug 14, 2019
Notice of opposition
Aug 14, 2019
Notice of opposition
Nov 26, 2018
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Oct 18, 2018
Decision to grant a European patent
Oct 1, 2018
(Electronic) Receipt
Oct 1, 2018
Filing of the translations of the claims
Oct 1, 2018
French translation of claims
Oct 1, 2018
German translation of the claims
Oct 1, 2018
Letter accompanying subsequently filed items
May 25, 2018
Communication of the registration of a transfer or change of name and/or address
May 23, 2018
Bibliographic data of the European patent application
May 23, 2018
Communication about intention to grant a European patent
May 23, 2018
Intention to grant (signatures)
May 23, 2018
Text intended for grant (clean copy)
May 23, 2018
Text intended for grant (version for approval)
May 18, 2018
Submission concerning change of applicant's address
Mar 29, 2018
Letter concerning fees and payments
Mar 29, 2018
Payment of fees and costs
Nov 15, 2017
(Electronic) Receipt
Nov 15, 2017
Amended claims with annotations
Nov 15, 2017
Amended description with annotations
Nov 15, 2017
Claims
Nov 15, 2017
Description
Nov 15, 2017
Letter accompanying subsequently filed items
Nov 15, 2017
Reply to communication from the Examining Division
Sep 11, 2017
Annex to the communication
Sep 11, 2017
Communication from the Examining Division
Aug 15, 2017
(Electronic) Receipt
Aug 15, 2017
Amended claims with annotations
Aug 15, 2017
Citation for the examination procedure
Aug 15, 2017
Citation for the examination procedure
Aug 15, 2017
Claims
Aug 15, 2017
Letter accompanying subsequently filed items
Aug 15, 2017
Reply to communication from the Examining Division
Aug 9, 2017
Communication of the registration of a transfer or change of name and/or address
Aug 1, 2017
Submission concerning a transfer of rights (applicant)
Jun 26, 2017
Grant of extension of time limit (examination procedure)
Jun 20, 2017
(Electronic) Receipt
Jun 20, 2017
Letter accompanying subsequently filed items
Jun 20, 2017
Request for extension of time limit to communication from the Examining Division
Feb 10, 2017
Annex to the communication
Feb 10, 2017
Communication from the Examining Division
Feb 6, 2017
Examination started
Oct 19, 2016
Communication of the registration of a transfer or change of name and/or address
Oct 14, 2016
Submission concerning change of applicant's address
Aug 3, 2016
Notification on forthcoming publication of bibliographic data
Jun 2, 2016
Communication regarding comments on written opinion/amendment of application/payment of claims fee
May 31, 2016
Communication to designated inventor
May 31, 2016
Communication to designated inventor
May 31, 2016
Communication to designated inventor
May 18, 2016
Copy of the international preliminary report on patentability
May 13, 2016
(Electronic) Receipt
May 13, 2016
Amended claims filed after receipt of (European) search report
May 13, 2016
Amended claims with annotations
May 13, 2016
Amendments received before examination
May 13, 2016
Request for entry into the European phase
Mar 4, 2016
Annex
Mar 4, 2016
Information on entry into European phase
Mar 4, 2016
Submission concerning representation
May 19, 2015
Priority document (electronically transmitted)
Apr 30, 2015
Copy of the international search report
Apr 30, 2015
Published international application - A1
Feb 23, 2015
Written opinion of the ISA, boxes No. I to VIII
Feb 23, 2015
Written opinion of the ISA, cover sheet
Feb 23, 2015
Written opinion of the ISA, supplemental box
Nov 3, 2014
Abstract
Nov 3, 2014
Annex
Nov 3, 2014
Claims
Nov 3, 2014
Description
Nov 3, 2014
Drawings

EP3060303

SHIRE HUMAN GENETIC THERAPIES

Application Number: EP14799919A
Filing Date: Oct 22, 2014
Status: Revoked; Sep 3, 2021
Publication Date: Nov 14, 2018
External Links: Slate, Register , Google Patents

IP Verse

Mrna Therapy For Argininosuccinate Synthetase Deficiency

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3060303